Related Experiment Video
Updated: Apr 20, 2026

11:44
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
8.1K
miRNAs in post-ischaemic angiogenesis and vascular remodelling
Jaimy Saif1, Costanza Emanueli
1*Bristol Heart Institute, School of Clinical Sciences, Bristol Royal Infirmary-Level 7, University of Bristol, Bristol BS2 8HW, U.K.
Biochemical Society Transactions
|November 18, 2014
Summary
MicroRNAs (miRNAs) regulate gene expression and are crucial for blood vessel formation. This review explores their role in repairing tissues after ischemia, highlighting their potential as biomarkers and therapeutic targets.
Area of Science:
- Molecular Biology
- Genetics
- Cardiovascular Biology
Background:
- MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression post-transcriptionally.
- miRNAs play significant roles in biological processes including angiogenesis and vascular remodeling.
- Dysregulation of miRNAs is implicated in various ischemic diseases.
Purpose of the Study:
- To review the role of miRNAs in post-ischemic tissue repair.
- To discuss the involvement of miRNAs in angiogenesis and ischemic diseases.
- To examine the potential of miRNAs in modulating stem/progenitor cell behavior for vascular repair.
- To explore the clinical utility of miRNAs as biomarkers and therapeutic targets.
Main Methods:
- Literature review of studies on miRNAs in ischemia, angiogenesis, and vascular repair.
- Analysis of miRNA involvement in stem and progenitor cell function.
- Discussion of current and future therapeutic strategies involving miRNAs.
Main Results:
- Numerous miRNAs are associated with angiogenesis and vascular remodeling in the context of ischemia.
- miRNAs influence the behavior of stem and progenitor cells, impacting vascular repair efficacy.
- Specific miRNAs show promise as indicators of disease state and potential therapeutic agents.
Conclusions:
- miRNAs are key regulators in post-ischemic vascular repair.
- Targeting miRNAs offers a promising avenue for developing novel therapies for ischemic conditions.
- Further research into miRNA mechanisms and clinical applications is warranted.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
4.0K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
4.0K
Mechanism of Angiogenesis
7.9K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.9K

